All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Ongoing | 2005-000459-14 | A Stratified Phase II Study of Cetuximab (ErbituxTM) for the Treatment of Recurrent Glioblastoma Multiforme / Estudio de fase II estratificado de cetuximab para el tratamiento del glioblastoma multifo... | not-yet-due | |
Not reported | 2006-001765-42 | A prospective and randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation (REVERSE study... | 2015-04-17 | due-trials |
Ongoing | 2008-000756-27 | Activity of sunitinib in esophageal cancer, melanoma and sarcoma. | not-yet-due | |
Reported results | 2009-009429-26 | A PILOT STUDY TO EVALUATE THE EFFECT OF TRIGGERING FINAL OOCYTE MATURATION WITH GnRHa OR hCG ON ENDOMETRIAL RECEPTIVITY PARAMETERS AND THE LUTEAL PHASE IN OOCYTE DONORS | 2012-01-13 | due-trials |
Not reported | 2009-011817-26 | A pilot study to assess the feasibility of unrelated umbilical cord blood transplantation with coinfusion of third-party mesenchymal stem cells after myeloablative or nonmyeloablative conditioning in ... | 2018-11-09 | due-trials |
Ongoing | 2009-012089-30 | Frequency and mechanisms of resistance to IGF-1 generation in non-GH deficient short children with low IGF-1 concentration | not-yet-due | |
Ongoing | 2010-018491-24 | Effect of aminobisphosphonates and statins on circulating Vy9Vd2-T cells | not-yet-due | |
Completed, but no date, and reported results | 2010-023058-35 | A Two-Stage Phase II Study of Autologous TriMix-DC Therapeutic Vaccine in Combination with Ipilimumab in Patients with Previously Treated Unresectable Stage III or IV Melanoma | bad-data | |
Other | 2010-023777-19 | Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants: the SToP-BPD study | not-yet-due | |
Ongoing | 2011-000900-16 | AA randomized phase II clinical trial on the efficacy of axitinib as a monotherapy or in combination with lomustine for the treatment of patients with recurrent glioblastoma | not-yet-due | |
Ongoing | 2011-001410-33 | Randomized phase II clinical trial on mRNA electroporated autologous dendritic cells for stage III/IV melanoma in patients who are free from measurable tumor lesions following the local treatment of m... | not-yet-due | |
Completed, but no date, and reported results | 2011-003321-99 | Comparison of Volulyte® versus Tetraspan® in patients undergoing cardiopulmonary bypass. | bad-data | |
Completed, report not yet due | 2011-005457-31 | The effect of the combination of midazolam with Ropivacaine in loco-regional anesthesia. Het effect van de combinatie van Ropivacaïne met Midazolam bij loco-regionale anesthesie. | 2024-08-06 | not-yet-due |
Ongoing | 2011-005534-19 | The effect of peri-operative anti-inflammatory treatment on postoperative muscle weakness and muscle fatigue in elderly elective surgery patients: a double blinded randomized placebo-controlled trial.... | not-yet-due | |
Reported results | 2012-000584-25 | Propofol and etomidate. Are they also safe for patients with Brugada-Syndrome? | 2018-03-31 | due-trials |
Listed as ongoing, but also has a completion date | 2012-005226-29 | Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease | 2015-08-31 | bad-data |
Completed, but no date, and reported results | 2013-000583-29 | Corifollitropin alfa followed by hp-HMG versus recombinant FSH in young poor ovarian responders. A multicentre randomized controlled clinical trial | bad-data | |
Ongoing | 2013-000665-36 | A phase II, open label study of everolimus with fulvestrant in postmenopausal women with hormone receptor-positive HER-2 negative AI and fulvestrant treated, locally advanced or metastatic breast canc... | not-yet-due | |
Completed, report not yet due | 2013-000795-15 | An open-label pilot clinical trial of MAGE-A3 and MAGE-C1 mRNA electroporated autologous dendritic cell vaccination in combination with lenalidomide maintenance therapy for multiple myeloma after firs... | 2024-09-17 | not-yet-due |
Ongoing | 2013-002373-22 | ThE SoF-Trial (SoFT) - The Effect of Sevelamer on FGF23 Trial - A clinical trial assessing the quantitative effect of phosphate binding therapy on FGF23. | not-yet-due | |
Reported results | 2013-002815-88 | Randomised comparative trial of Bupivacaine and 2-Chloroprocaine by caesarean section. Vergelijkende gerandomiseerde studie van BupivacaÏne en 2- ChloroprocaÏne bij keizersnede. | 2013-12-31 | due-trials |
Completed, report not yet due | 2013-004206-26 | The effect of methylphenidate (Ritalin ®) on the severity of stuttering. | 2024-07-22 | not-yet-due |
Completed, report not yet due | 2013-004232-29 | A phase II proof of concept study to evalute the efficacy and safety of deep subcutaneous lanreotide Autogel 120 mg / 28 days on symptoms and healing of the esophageal and gastric mucosa in patients w... | 2024-08-05 | not-yet-due |
Completed, report not yet due | 2013-004908-20 | Cerebral effect of paracetamol measured by f-MRI | 2024-08-06 | not-yet-due |
Ongoing | 2013-004966-33 | A phase II clinical trial on the combination of dabrafenib and trametinib for BRAF-inhibitor pretreated patients with advanced BRAF V600 mutant melanoma | not-yet-due | |
Ongoing | 2013-005475-41 | Sulfamethoxazole treatment of primary PREPL deficiency Sulfamethoxazole ter behandeling van primaire PREPL deficiëntie | not-yet-due | |
Ongoing | 2013-005528-40 | Long-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a genetic model of epilepsy – Tuberous Sclerosis Complex. Een lange-termijn, prospectieve studie om k... | not-yet-due | |
Completed, but no date | 2014-000308-82 | Lanthanum Carbonate (Fosrenol®) to reduce oxalate excretion in patients with secondary hyperoxaluria and nephrolithiasis: a short-term, prospective, open-label, efficacy and safety clinical trial | bad-data | |
Completed, report not yet due | 2014-000678-20 | Does isocapnic hyperventilation hasten early recovery with sevoflurane and desflurane in O2/air? | 2024-08-06 | not-yet-due |
Not reported | 2014-001835-35 | Transdermal testosterone gel for poor ovarian responders. A multicenter double-blind placebo controlled randomized trial. | 2023-07-11 | due-trials |
Completed, report not yet due | 2014-004713-91 | Epidural ropivacaine as part of a multimodal postoperative pain treatment following thoracolumbar spinal fusion surgery. | 2024-08-06 | not-yet-due |
Completed, report not yet due | 2015-000537-69 | Real time monitoring of blood propofol concentration | 2024-08-06 | not-yet-due |
Ongoing | 2015-000689-79 | Rectal preserving treatment for early rectal cancer. A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancers. | not-yet-due | |
Other | 2015-002328-24 | Evaluation of 68GaNOTA-Anti-HER2 VHH1 uptake in brain metastasis of cancer patients | not-yet-due | |
Completed, report not yet due | 2015-002645-54 | Comparison of efficacy between dexmedetomidine (DEX) and nicardipine (NIC) in adult facial surgery | 2024-08-06 | not-yet-due |
Completed, but no date, and reported results | 2015-002744-14 | Comparative study with prilocaine 1% and prilocaine 1.5% for ultrasound guided axillary brachial plexus blockade | bad-data | |
Not reported | 2015-004251-47 | Validation of central venous (Port A Cath®) blood draws for ciprofloxacin pharmacokinetic research in patients under treatment for childhood cancer. Validatie van bloedafnames via een Port A Cath® ... | 2020-06-10 | due-trials |
Completed, report not yet due | 2015-005146-55 | The effect of methylphenidate (Ritalin®) on the severity of stuttering. | 2024-07-22 | not-yet-due |
Ongoing | 2015-005154-35 | N-acetylcysteine for the treatment of cannabis dependence: working mechanisms | not-yet-due | |
Completed, report not yet due | 2016-000228-24 | Eradication of H. pylori infection in Belgium: bismuth versus first line therapy | 2024-08-05 | not-yet-due |
Reported results | 2016-000813-63 | Comparative doubleblind study with prilocaine 2 % and 2-chloroprocaine for elective caesarean section. | 2016-12-31 | due-trials |
Ongoing | 2016-002164-13 | Quantification of 68GaNOTA-Anti-HER2 VHH1 Uptake in metastasis of Breast carcinoma and cancer patients and Assessment of Repeatability – Pilot study | not-yet-due | |
Completed, report not yet due | 2016-002323-28 | Blood concentration and pharmacokinetic analysis of propofol following administration of single induction dose in small children | 2024-08-06 | not-yet-due |
Completed, report not yet due | 2016-003198-17 | A Prospective Interventional Pilot Study on the Use of Valproic Acid for Treatment of Idiopathic Nephrotic Syndrome | 2024-07-19 | not-yet-due |
No trial status on register | 2016-003673-18 | Can we with vitamin D3, improve the innate immune system? Kunnen we door middel van een behandeling met vitamine D3, het aangeboren immuunsysteem verbeteren? Peut-on au moyen d'un traitement ave... | bad-data | |
Reported results | 2017-000200-23 | Phase II clinical trial on the combination of avelumab and axitinib for the treatment of patients with recurrent glioblastoma | 2020-09-16 | due-trials |
Completed, report not yet due | 2017-001253-13 | Does cerebral hypoperfusion play a role in reduced axonal metabolism and clinical disability in patients with multiple sclerosis ? Speelt cerebrale hypoperfusie een rol in het verminderd axonaal me... | 2024-09-30 | not-yet-due |
Exempt | 2017-001471-23 | Phase I/IIa study to evaluate the safety, biodistribution, radiation dosimetry and tumor imaging potential of 68GaNOTA-Anti-MMR-VHH2, a new radiopharmaceutical for in vivo imaging of Tumour-Associated... | not-yet-due | |
Ongoing | 2017-001556-67 | The effect of emollients on pruritus in psoriasis | not-yet-due | |
Ongoing | 2017-002571-25 | A comparison between corifollitropin alfa and recombinant FSH for follicular recruitment in women with polycystic ovaries who undergo IVM treatment | not-yet-due | |
Other | 2017-003280-35 | AMENDMENT TITLE: Phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ / CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and AS01 in combination with intravenously... | not-yet-due | |
Completed, report not yet due | 2017-004038-28 | Comparative Prospective Randomized Study in Postoperative Cardiac Surgery Patients on Analgesia with Morphine Continuous Infusion or Sublingual Sufentanil (Zalviso®). | 2024-08-06 | not-yet-due |
Ongoing | 2017-004429-34 | Histological and Transcriptional Changes caused by Endometrial Flushing with Lipiodol: A Cross Over Study. | not-yet-due | |
Completed, but no date | 2017-005005-12 | Initiation of ovarian stimulation with recombinant-human FSH (Bemfola®) in the late follicular phase, a randomised controlled study. | bad-data | |
Completed, but no date | 2018-000016-19 | Randomized comparative double blind prospective study with hyperbaric prilocaine 2 % and 3 different doses of sufentanil for elective caesarean section. | bad-data | |
Completed, report not yet due | 2018-000045-40 | The effects of nitrous oxide on human vision | 2024-08-06 | not-yet-due |
Completed, report not yet due | 2018-000105-23 | Oral dydrogesterone (OD) versus micronized vaginal progesterone (MVP) for luteal phase support (LPS) in IVF/ICSI: pharmacokinetics and the impact on the endometrium, the microbiota of the genital trac... | 2024-02-14 | not-yet-due |
Not reported | 2018-000689-13 | Clinical pregnancy rate for frozen embryo transfer with HRT: a pilot study comparing 1 versus 2 weeks of treatment | 2023-05-15 | due-trials |
Other | 2018-001751-12 | Vitamin D Supplementation to increase free testosterone in Type 2 Diabetes Mellitus men: a Placebo-controlled Randomized Clinical Trial | not-yet-due | |
Other | 2018-002000-13 | Effect of recombinant FSH dosing following corifollitropin alfa in patients undergoing IVF/ICSI in a GnRH antagonist protocol: a randomized controlled dose-finding study. | not-yet-due | |
Ongoing | 2018-003156-20 | Natural cycle versus hormone replacement therapy cycle for a frozen-thawed embryo transfer in PGT patients: a randomised trial. | not-yet-due | |
Ongoing | 2018-004003-39 | A stratified dual-arm open-label two-stage phase 2 trial of trametinib in patients with advanced pretreated BRAFV600 wild-type melanoma | not-yet-due | |
Not reported | 2019-000709-55 | Sugammadex dose-finding study for reversal of deep rocuronium-induced neuromuscular block | 2022-11-16 | due-trials |
Not reported | 2019-000971-17 | Double trigger and ovum retrieval vs. conventional antagonist ovarian stimulation protocol in poor prognosis women undergoing IVF/ICSI: A pilot study | 2023-06-29 | due-trials |
Ongoing | 2019-002094-55 | Safety and feasibility of S-Caine patch use in children under the age of three Veiligheid en haalbaarheid van S-Caine patch gebruik bij kinderen onder de leeftijd van drie | not-yet-due | |
Ongoing | 2019-003668-32 | A randomized phase II clinical trial of SBRT and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/ CD141 (BDCA-3)+ myeloid dendritic cells in NSCLC | not-yet-due | |
Other | 2019-004671-39 | The effect of handheld-multimedia versus midazolam premedication on the level of perioperative anxiety in pediatric day-care. A randomized controlled trial. | not-yet-due | |
Completed, reported early | 2019-004750-28 | Electrocardiographic And Clinical Effects Of Target-Controlled Infusion Of Propofol In Adults With Brugada Syndrome. A Pilot Study. | 2024-09-16 | not-yet-due |
Ongoing | 2020-002483-31 | Phase II study to evaluate the clinical potential of 68GaNOTA-Anti-MMR-VHH2 for in vivo imaging of MMR-expressing Macrophages by means of Positron Emission Tomography (PET) in oncological lesions, car... | not-yet-due | |
Completed, reported early | 2020-003682-19 | Post-operative patient controlled intravenous oxyco-done vs patient controlled intrav nous piritramide. A randomized controlled trial. | 2023-10-16 | not-yet-due |
Ongoing | 2020-004491-17 | Dydrogesterone versus micronized vaginal progesterone (MVP) for luteal phase support (LPS) in hormone replacement therapy (HRT) frozen embryo transfer (FET) cycles. | not-yet-due | |
Completed, reported early | 2020-004723-17 | Clinical usefulness and influence on oesophageal motility of pyridostigmine for dysphagia in systemic sclerosis. Klinische meerwaarde van pyridostigmine bij patiënten met systeemsclerose die dysfa... | 2024-05-06 | not-yet-due |
Ongoing | 2020-005208-20 | Depo-Trigger trial: GnRH agonist DEPOt TRIGGER for final oocyte maturation in breast cancer patients undergoing fertility preservation: a pilot study. | not-yet-due | |
Ongoing | 2020-005914-16 | COmbining Interventions of fertility preservation to Mitigate fertility loss after BReAst cancer | not-yet-due | |
Completed, report not yet due | 2021-005426-18 | Diuretic Treatment in Acute Heart Failure with Volume Overload Guided by Serial Spot Urine Sodium Assessment | 2024-07-01 | not-yet-due |
Other | 2021-005575-40 | A phase II study to evaluate the imaging potential of 68GaNOTA-Anti-MMR VHH2 for in vivo imaging of MMR-expressing Macrophages by means of Positron Emission Tomography (PET) in patients with non-small... | not-yet-due | |
Other | 2022-001291-34 | A phase-2 clinical trial of regorafenib in patients with pretreated advanced melanoma | not-yet-due | |
Not reported | 2022-002310-16 | Endometrial gene expression profiles during ovarian stimulation with recombinant human FSH with or without the addition of recombinant human LH in genuine poor responders. | 2023-07-10 | due-trials |
Other | 2022-002836-30 | Investigating fundamental mechanisms of mental and physical fatigue using neurotransmitter reuptake inhibitors and electroencephalography: a randomized counterbalanced crossover trial | not-yet-due | |
Other | 2022-003049-37 | Luteal phase ovarian stimulation with Follitropin delta and dydrogesterone: a randomized cross over pilot trial | not-yet-due | |
Other | 2022-003925-23 | Pain medication tapering for patients with Persistent Spinal Pain Syndrome Type II, treated with Spinal Cord Stimulation. | not-yet-due |